FNCRX | FRNRX | FNCRX / FRNRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 30 years | - |
Gain YTD | 7.999 | 8.038 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 338M | 338M | 100% |
Annual Yield % from dividends | 1.51 | 1.83 | 82% |
Returns for 1 year | 16.08 | 16.96 | 95% |
Returns for 3 years | 29.49 | 31.88 | 93% |
Returns for 5 years | 49.16 | 52.42 | 94% |
Returns for 10 years | 18.45 | 22.01 | 84% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CPODX | 50.46 | 0.73 | +1.47% |
Morgan Stanley Insight I | |||
TSAGX | 57.17 | 0.65 | +1.15% |
Touchstone Large Company Growth A | |||
FSCHX | 14.04 | 0.11 | +0.79% |
Fidelity Select Chemicals | |||
GEMHX | 11.98 | 0.01 | +0.08% |
Goldman Sachs Emerging Mkts Eq ex. Chn A | |||
BGSIX | 74.08 | N/A | N/A |
BlackRock Technology Opportunities Instl |